Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity
Context: The hypothalamic circuit has an essential role in the regulation of appetite and energy expenditure. Pathogenic variants in genes involved in the hypothalamic leptin–melanocortin pathway, including melanocortin-4-receptor (MC4R), have been associated with monogenic obesity.Objective: To det...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00081/full |
id |
doaj-e98d2025a9bc49f8a4cacb8362dbfde3 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Petra Loid Petra Loid Petra Loid Taina Mustila Taina Mustila Riikka E. Mäkitie Riikka E. Mäkitie Riikka E. Mäkitie Heli Viljakainen Heli Viljakainen Anders Kämpe Päivi Tossavainen Marita Lipsanen-Nyman Marita Lipsanen-Nyman Minna Pekkinen Minna Pekkinen Minna Pekkinen Outi Mäkitie Outi Mäkitie Outi Mäkitie Outi Mäkitie |
spellingShingle |
Petra Loid Petra Loid Petra Loid Taina Mustila Taina Mustila Riikka E. Mäkitie Riikka E. Mäkitie Riikka E. Mäkitie Heli Viljakainen Heli Viljakainen Anders Kämpe Päivi Tossavainen Marita Lipsanen-Nyman Marita Lipsanen-Nyman Minna Pekkinen Minna Pekkinen Minna Pekkinen Outi Mäkitie Outi Mäkitie Outi Mäkitie Outi Mäkitie Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity Frontiers in Endocrinology childhood obesity hypothalamus appetite regulation hyperphagia MC4R |
author_facet |
Petra Loid Petra Loid Petra Loid Taina Mustila Taina Mustila Riikka E. Mäkitie Riikka E. Mäkitie Riikka E. Mäkitie Heli Viljakainen Heli Viljakainen Anders Kämpe Päivi Tossavainen Marita Lipsanen-Nyman Marita Lipsanen-Nyman Minna Pekkinen Minna Pekkinen Minna Pekkinen Outi Mäkitie Outi Mäkitie Outi Mäkitie Outi Mäkitie |
author_sort |
Petra Loid |
title |
Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity |
title_short |
Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity |
title_full |
Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity |
title_fullStr |
Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity |
title_full_unstemmed |
Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity |
title_sort |
rare variants in genes linked to appetite control and hypothalamic development in early-onset severe obesity |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2020-02-01 |
description |
Context: The hypothalamic circuit has an essential role in the regulation of appetite and energy expenditure. Pathogenic variants in genes involved in the hypothalamic leptin–melanocortin pathway, including melanocortin-4-receptor (MC4R), have been associated with monogenic obesity.Objective: To determine the rate and spectrum of rare variants in genes involved in melanocortin pathway or hypothalamic development in patients with severe early-onset obesity (height-adjusted weight >60% before age 10 years).Methods: We used a custom-made targeted exome sequencing panel to assess peripheral blood DNA samples for rare (minor allele frequency <0.5%), pathogenic/likely pathogenic variants in 24 genes related to the hypothalamic circuit in 92 subjects (51% males, median age 13.7 years) with early-onset severe obesity (median body mass index (BMI) Z-score + 4.0).Results: We identified a novel frameshift deletion in MC4R (p.V103Afs5*) in two unrelated patients and a previously reported MC4R variant (p.T112M) in one patient. In addition, we identified rare heterozygous missense variants in ADCY3 (p.G1110R), MYT1L (p.R807Q), ISL1 (p.I347F), LRP2 (p.R2479I, and p.N3315S) and a hemizygous missense variant in GRPR (p.L87M) (each in one patient), possibly contributing to the obesity phenotype in these patients. Altogether 8 % (7/92) of the subjects had rare pathogenic/likely pathogenic variants in the studied genes.Conclusions: Rare genetic variants within the hypothalamic circuit are prevalent and contribute to the development of severe early-onset obesity. Targeted exome sequencing is useful in identifying affected subjects. Further studies are needed to evaluate the variants' clinical significance and to define optimal treatment. |
topic |
childhood obesity hypothalamus appetite regulation hyperphagia MC4R |
url |
https://www.frontiersin.org/article/10.3389/fendo.2020.00081/full |
work_keys_str_mv |
AT petraloid rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT petraloid rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT petraloid rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT tainamustila rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT tainamustila rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT riikkaemakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT riikkaemakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT riikkaemakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT heliviljakainen rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT heliviljakainen rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT anderskampe rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT paivitossavainen rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT maritalipsanennyman rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT maritalipsanennyman rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT minnapekkinen rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT minnapekkinen rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT minnapekkinen rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT outimakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT outimakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT outimakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity AT outimakitie rarevariantsingeneslinkedtoappetitecontrolandhypothalamicdevelopmentinearlyonsetsevereobesity |
_version_ |
1725174997865988096 |
spelling |
doaj-e98d2025a9bc49f8a4cacb8362dbfde32020-11-25T01:10:24ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922020-02-011110.3389/fendo.2020.00081512622Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe ObesityPetra Loid0Petra Loid1Petra Loid2Taina Mustila3Taina Mustila4Riikka E. Mäkitie5Riikka E. Mäkitie6Riikka E. Mäkitie7Heli Viljakainen8Heli Viljakainen9Anders Kämpe10Päivi Tossavainen11Marita Lipsanen-Nyman12Marita Lipsanen-Nyman13Minna Pekkinen14Minna Pekkinen15Minna Pekkinen16Outi Mäkitie17Outi Mäkitie18Outi Mäkitie19Outi Mäkitie20Children's Hospital, Helsinki University Hospital, Helsinki, FinlandFolkhälsan Research Center, Genetics Research Program, Helsinki, FinlandResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, FinlandDepartment of Pediatrics, Seinäjoki Central Hospital, Seinäjoki, FinlandCity of Turku, Welfare Division, Preventive Healthcare, Turku, FinlandFolkhälsan Research Center, Genetics Research Program, Helsinki, FinlandResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, FinlandMolecular Endocrinology Laboratory, Department of Medicine, Hammersmith Campus, Imperial College London, London, United KingdomFolkhälsan Research Center, Genetics Research Program, Helsinki, FinlandThe Department of Food and Nutrition, University of Helsinki, Helsinki, FinlandDepartment of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Genetics, Karolinska University Hospital, Stockholm, SwedenDepartment of Children and Adolescents, PEDEGO Research Unit, University of Oulu, Oulu, FinlandChildren's Hospital, Helsinki University Hospital, Helsinki, FinlandResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, FinlandChildren's Hospital, Helsinki University Hospital, Helsinki, FinlandFolkhälsan Research Center, Genetics Research Program, Helsinki, FinlandResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, FinlandChildren's Hospital, Helsinki University Hospital, Helsinki, FinlandFolkhälsan Research Center, Genetics Research Program, Helsinki, FinlandResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, FinlandDepartment of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Genetics, Karolinska University Hospital, Stockholm, SwedenContext: The hypothalamic circuit has an essential role in the regulation of appetite and energy expenditure. Pathogenic variants in genes involved in the hypothalamic leptin–melanocortin pathway, including melanocortin-4-receptor (MC4R), have been associated with monogenic obesity.Objective: To determine the rate and spectrum of rare variants in genes involved in melanocortin pathway or hypothalamic development in patients with severe early-onset obesity (height-adjusted weight >60% before age 10 years).Methods: We used a custom-made targeted exome sequencing panel to assess peripheral blood DNA samples for rare (minor allele frequency <0.5%), pathogenic/likely pathogenic variants in 24 genes related to the hypothalamic circuit in 92 subjects (51% males, median age 13.7 years) with early-onset severe obesity (median body mass index (BMI) Z-score + 4.0).Results: We identified a novel frameshift deletion in MC4R (p.V103Afs5*) in two unrelated patients and a previously reported MC4R variant (p.T112M) in one patient. In addition, we identified rare heterozygous missense variants in ADCY3 (p.G1110R), MYT1L (p.R807Q), ISL1 (p.I347F), LRP2 (p.R2479I, and p.N3315S) and a hemizygous missense variant in GRPR (p.L87M) (each in one patient), possibly contributing to the obesity phenotype in these patients. Altogether 8 % (7/92) of the subjects had rare pathogenic/likely pathogenic variants in the studied genes.Conclusions: Rare genetic variants within the hypothalamic circuit are prevalent and contribute to the development of severe early-onset obesity. Targeted exome sequencing is useful in identifying affected subjects. Further studies are needed to evaluate the variants' clinical significance and to define optimal treatment.https://www.frontiersin.org/article/10.3389/fendo.2020.00081/fullchildhood obesityhypothalamusappetite regulationhyperphagiaMC4R |